Trichomoniasis

SUMMARY Trichomoniasis is perhaps the most common curable sexually transmitted disease worldwide, yet few resources are devoted to its control. It is associated with potentially serious complications such as preterm birth and human immunodeficiency virus acquisition and transmission. The immunology of a related organism, Tritrichomonas foetus, which causes disease in cattle, has been investigated to some extent, but more work is needed for the human strain, Trichomonas vaginalis. In addition, although trichomoniasis is easily treated with oral metronidazole, there is concern that the number of strains resistant to this antibiotic are increasing, and currently no alternative is licensed in the United States. As more is appreciated concerning the important public health implications of this common infection, more work will need to be done in understanding the diagnosis, treatment, and immunology of this organism.

• Publication year

  1938

• Venue

  Clinical Microbiology Reviews

• Publication date

  1938-08-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1128/CMR.17.4.794-803.2004PMID 15489349PMCID PMC523559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tinidazole: A Review of its Antiprotozoal Activity and Therapeutic Efficacy

  2012cited by this paper
• In vitro effect of metronidazole on the ultrastructure of Trichomonas vaginalis donné.

  2009cited by this paper
• Electron microscopy of Trichomonas vaginalis Donné: interaction with vaginal epithelium in human trichomoniasis.

  2009cited by this paper
• Patient-Delivered Partner Treatment for Trichomonas vaginalis Infection: A Randomized Controlled Trial

  2006cited by this paper
• Prevalence of Trichomonas vaginalis Isolates with Resistance to Metronidazole and Tinidazole

  2006cited by this paper
• The Associations Between Pelvic Inflammatory Disease, Trichomonas vaginalis Infection, and Positive Herpes Simplex Virus Type 2 Serology

  2006cited by this paper
• Use of an Adaptation of a Commercially Available PCR Assay Aimed at Diagnosis of Chlamydia and Gonorrhea To Detect Trichomonas vaginalis in Urogenital Specimens

  2006cited by this paper
• Cytotoxic potential of cervical mucus on Trichomonas vaginalis to prevent upper genital tract infections.

  2006cited by this paper
• Trichomonas empyema with respiratory failure.

  2006cited by this paper
• Diagnosis of Trichomonas vaginalis infection: The sensitivities and specificities of microscopy, culture and PCR assay.

  2006cited by this paper
• Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.

  2005cited by this paper
• The Amitochondriate Eukaryote Trichomonas vaginalis Contains a Divergent Thioredoxin-linked Peroxiredoxin Antioxidant System*

  2004cited by this paper
• tvcp12: a novel Trichomonas vaginalis cathepsin L-like cysteine proteinase-encoding gene.

  2004cited by this paper
• Performance of a New, Rapid Assay for Detection of Trichomonas vaginalis

  2004cited by this paper
• Ultrastructural and immunohistochemical studies on Trichomonas vaginalis adhering to and phagocytizing genitourinary epithelial cells.

  2004cited by this paper
• Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis.

  2004cited by this paper
• Evaluation of vaginal complaints.

  2004cited by this paper
• Production of Interleukin-8 by Human Neutrophils Stimulated with Trichomonas vaginalis

  2004cited by this paper
• Purification and Analysis of a Phospholipase A2-Like Lytic Factor of Trichomonas vaginalis

  2004cited by this paper
• Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.

  2004cited by this paper
• High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.

  2003cited by this paper
• Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance

  2003cited by this paper
• Trichomonas vaginalis: evaluating capsid proteins of dsRNA viruses and the dsRNA virus within patients attending a sexually transmitted disease clinic.

  2003cited by this paper
• Leukocyte uropod formation and membrane/cytoskeleton linkage in immune interactions

  2003cited by this paper
• Addition of Treatment for Trichomoniasis to Syndromic Management of Urethritis in Malawi:: A Randomized Clinical Trial

  2003cited by this paper
• In Vitro Metronidazole and Tinidazole Activities against Metronidazole- Resistant Strains of Trichomonas vaginalis

  2003cited by this paper
• Sexually transmitted diseases treatment guidelines

  2003cited by this paper
• Trichomonas vaginalis orchitis with associated severe oligoasthenoteratospermia and hypogonadism.

  2003cited by this paper
• Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda.

  2003cited by this paper
• Accuracy of detection of trichomonas vaginalis organisms on a liquid-based papanicolaou smear.

  2003cited by this paper
• Double stranded RNA virus in South African Trichomonas vaginalis isolates

  2003cited by this paper
• 'Shelf life' of Trichomonas vaginalis.

  2003cited by this paper
• Pulmonary coinfection by Trichomonas vaginalis and Pneumocystis sp. as a novel manifestation of AIDS.

  2003cited by this paper
• Validation of a Urine-Based PCR-Enzyme-Linked Immunosorbent Assay for Use in Clinical Research Settings To Detect Trichomonas vaginalis in Men

  2003cited by this paper
• Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.

  2002cited by this paper
• Demonstration of Trichomonas vaginalis in tracheal aspirates in infants with early respiratory failure

  2002cited by this paper
• How laminin-1 can be recognized by the protozoan parasite Tritrichomonas foetus: possible role played by the extracellular matrix glycoprotein in both cytoadhesion and cytotoxicity exerted by the parasite.

  2002cited by this paper
• Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection.

  2002cited by this paper
• Improved Detection by DNA Amplification of Trichomonas vaginalis in Males

  2002cited by this paper
• Characterization of an Iron-responsive Promoter in the Protozoan Pathogen Trichomonas vaginalis *

  2002cited by this paper
• Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.

  2001influential reference
• Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.

  2001cited by this paper
• Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.

  2001cited by this paper
• Detection of Trichomonosis in Vaginal and Urine Specimens from Women by Culture and PCR

  2000cited by this paper
• Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility.

  2000cited by this paper
• The complete cDNA sequence of a type II Trichomonas vaginalis virus.

  2000cited by this paper
• Lymph node infection by Trichomonas tenax: report of a case with co-infection by Mycobacterium tuberculosis.

  2000cited by this paper
• Cytopathogenic Effect of Trichomonas vaginalis on Human Vaginal Epithelial Cells Cultured In Vitro

  2000cited by this paper
• CP30, a Cysteine Proteinase Involved inTrichomonas vaginalis Cytoadherence

  2000cited by this paper
• Origins of hydrogenosomes and mitochondria: evolution and organelle biogenesis.

  2000cited by this paper
• A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.

  2000cited by this paper
• Incidence and Predictors of Reinfection with Trichomonas vaginalis in HIV‐infected Women

  2000cited by this paper
• [Centers for Disease Control and Prevention (CDC)].

  2000cited by this paper
• Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections.

  2000cited by this paper
• Comparative Prevalence of Infection With Trichomonas vaginalis Among Men Attending a Sexually Transmitted Diseases Clinic

  2000cited by this paper
• The flagellated parasite Trichomonas vaginalis: new insights into cytopathogenicity mechanisms.

  1999cited by this paper
• Diagnosis of Trichomonas vaginalis Infection by PCR Using Vaginal Swab Samples

  1999cited by this paper
• Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel.

  1999cited by this paper
• Delayed versus Immediate Bedside Inoculation of Culture Media for Diagnosis of Vaginal Trichomonosis

  1999cited by this paper
• Topley and Wilson's Microbiology and Microbial Infections

  1999cited by this paper
• Trichomonas vaginalis as a cause of urethritis in Malawian men.

  1999cited by this paper
• Diagnosis of trichomoniasis by polymerase chain reaction.

  1999cited by this paper
• Improved Diagnosis of Trichomonas vaginalis Infection by PCR Using Vaginal Swabs and Urine Specimens Compared to Diagnosis by Wet Mount Microscopy, Culture, and Fluorescent Staining

  1999cited by this paper
• Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United States

  1999cited by this paper
• Metronidazole-resistant vaginal trichomoniasis--an emerging problem.

  1999cited by this paper
• Identification of Trichomonas vaginalis alpha-actinin as the most common immunogen recognized by sera of women exposed to the parasite.

  1999cited by this paper
• Molecular evolution inferred from small subunit rRNA sequences: what does it tell us about phylogenetic relationships and taxonomy of the parabasalids?

  1999cited by this paper
• Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor.

  1998cited by this paper
• Cure of metronidazole- and tinidazole-resistant trichomoniasis with use of high-dose oral and intravaginal tinidazole.

  1998cited by this paper
• Characterization of Trichomonas vaginalis AP33 adhesin and cell surface interactive domains.

  1998cited by this paper
• Cytologic detection of Trichomonas esophagitis in a patient with acquired immunodeficiency syndrome

  1998cited by this paper
• The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women.

  1998cited by this paper
• Global prevalence and incidence estimates of selected curable STDs.

  1998cited by this paper
• Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention.

  1998cited by this paper
• Trichomonas vaginalis and amplification of HIV-1 transmission.

  1998influential reference
• Genital and systemic immune responses in a murine model of Tritrichomonas foetus infection.

  1998cited by this paper
• Trichomonas tenax empyema in an immunocompromised patient with advanced cancer.

  1998cited by this paper
• Colorimetric one-tube nested PCR for detection of Trichomonas vaginalis in vaginal discharge

  1997cited by this paper
• Polymerase chain reaction analysis of distal vaginal specimens: a less invasive strategy for detection of Trichomonas vaginalis.

  1997cited by this paper
• Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery

  1997cited by this paper
• Mouse strain and age affect susceptibility to experimentally induced genital trichomoniasis.

  1997cited by this paper
• Targeting and translocation of proteins into the hydrogenosome of the protist Trichomonas: similarities with mitochondrial protein import

  1997cited by this paper
• HIV and reproductive tract infections in a total village population in rural Kilimanjaro, Tanzania: women at increased risk.

  1997cited by this paper
• Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis

  1997cited by this paper
• An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole.

  1996cited by this paper
• Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection

  1996influential reference
• Lesions of Experimental Genital Tritrichomonas foetus Infections in Estrogenized BALB/c Mice

  1996cited by this paper
• Detection of Trichomonas vaginalis in endocervical and ectocervical smears

  1996cited by this paper
• Analysis for adhesins and specific cytoadhesion of Trichomonas vaginalis.

  1995cited by this paper
• Cloning and molecular characterization of two genes encoding adhesion proteins involved in Trichomonas vaginalis cytoadherence

  1995cited by this paper
• Should screening of genital infections be part of antenatal care in areas of high HIV prevalence? A prospective cohort study from Kigali, Rwanda, 1992-1993. The Pregnancy and HIV (EGE) Group.

  1995cited by this paper
• Salivary trichomoniasis. A case report of infestation of a submaxillary gland by Trichomonas tenax.

  1995cited by this paper
• Immunohistochemical Detection of Tritrichomonas Foetus in Formalin-Fixed, Paraffin-Embedded Sections of Bovine Placenta and Fetal Lung

  1995cited by this paper
• Trichomoniasis in Men: Old Issues and New Data

  1995cited by this paper
• Beta-tubulin genes of Trichomonas vaginalis.

  1994cited by this paper
• Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies.

  1994cited by this paper
• Identification and molecular cloning of four cysteine proteinase genes from the pathogenic protozoon Trichomonas vaginalis.

  1994cited by this paper
• CHAPTER 1 – Trichomonads of Importance in Human Medicine Including Dientamoeba fragilis

  1994cited by this paper
• Trichomonas vaginalis with a double-stranded RNA virus has upregulated levels of phenotypically variable immunogen mRNA

  1994cited by this paper
• Trichomoniasis in non-gonococcic urethritis among male patients.

  1994cited by this paper

• Research Progress in the Treatment of Vaginitis With Bioactive Compounds: Targeting of Vaginal Microflora

  2026cites this paper
• Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review

  2025cites this paper
• Forensic Microbiology: Challenges in Detecting Sexually Transmitted Infections

  2025influential citation
• Trichomoniasis in Men: A Neglected Factor in Male Infertility?

  2025cites this paper
• Microbial spectrum of cervicovaginal discharge in symptomatic Indian women of reproductive age group

  2025cites this paper
• Trichomonas vaginalis extracellular vesicles suppress IFNε-mediated responses driven by its intracellular bacterial symbiont Mycoplasma hominis

  2025cites this paper
• Spectrum and Prevalence of Infections Detected in Liquid-based Cytology of Cervical Smears

  2025cites this paper
• Global burden of trichomoniasis: current status, trends, and projections (1990–2021)

  2025cites this paper
• Prevalence and bio-clinical characterisation of Trichomonas vaginalis infection in a large cohort of French patients screened using a molecular syndromic panel for sexually transmitted infections.

  2025cites this paper
• Sexually transmitted infections and bacterial vaginosis in women of child-bearing age in Antananarivo, Madagascar: prevalence and risk factors from a cross-sectional study

  2025cites this paper
• Influence of DNA methylation and chromatin accessibility on regulation of gene expression during Trichomonas vaginalis-host cell interaction

  2025cites this paper
• Does trichomoniasis, the most common nonviral sexually transmitted disease in Saudi Arabia and the globe, get all the focus it requires?

  2025cites this paper
• Role of histone modification in chromatin-mediated transcriptional repression in protozoan parasite Trichomonas vaginalis

  2024cites this paper
• The Past, Present, and Future in the Diagnosis of a Neglected Sexually Transmitted Infection: Trichomoniasis

  2024cites this paper
• Mucoadhesive polyelectrolyte complexes of fucoidan and chitin nanowhiskers to prolong the antiprotozoal activity of metronidazole.

  2024cites this paper
• Epidemiology of Trichomonas vaginalis infection in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions

  2024cites this paper
• Case series on Trichomonas vaginalis infections: impact of proper sample collection and diagnostic stewardship

  2024cites this paper
• Trichomonas vaginalis extracellular vesicles up-regulate and directly transfer adherence factors promoting host cell colonization

  2024cites this paper
• Prevalence of Trichomonas vaginalis infection and associated factors among parturients in Lagos: A multicenter descriptive cross-sectional study

  2024cites this paper
• A novel detection method based on MIRA-CRISPR/Cas13a-LFD targeting the repeated DNA sequence of Trichomonas vaginalis

  2024cites this paper
• ՏՐԻԽՈՄՈՆԱՍ ՎԱԳԻՆԱԼԻՍ ՎԻՐՈՒՍԻ (TVV) ԱԶԴԵՑՈՒԹՅՈՒՆԸ ԿԱՆԱՆՑ ՄԻԶԱՍԵՌԱԿԱՆ ՏՐԻԽՈՄՈՆԻԱԶԻ ՎՐԱ

  2024cites this paper
• Կանանց միզասեռական տրիխոմոնիազի առանձնահատկությունները

  2024cites this paper
• Drug Repurposing in the Chemotherapy of Infectious Diseases

  2024cites this paper
• Distinct substrate specificities of the three catalytic subunits of the Trichomonas vaginalis proteasome

  2024cites this paper
• Interaction of human neutrophils with Trichomonas vaginalis protozoan highlights lactoferrin secretion.

  2024cites this paper
• Carrageenan/Chitin Nanowhiskers Cryogels for Vaginal Delivery of Metronidazole

  2023cites this paper
• Comparative Study of the Effect of Sophora alopecuroides Plant Extract on Trichomonas vaginalis Parasite In Vitro

  2023cites this paper
• Effects of SQ109 on Trichomonas vaginalis.

  2023cites this paper
• Prevalence of Trichomonas vaginalis by polymerase chain reaction-based molecular method among symptomatic women from Northern India

  2023cites this paper
• Inflammatory responses during trichomoniasis: The role of Toll‐like receptors and inflammasomes

  2023cites this paper
• Exploring the interplay between Trichomonas vaginalis, Human Papillomavirus and the microbiota

  2023cites this paper
• Comparison of Three Methods for Diagnosing Trichomoniasis in Female Patients with Sexual Activity Attended at a Hospital in Peru

  2023cites this paper
• A review of the bioactive components and pharmacological properties of Lavandula species

  2023cites this paper
• Diagnostic utility of vaginal cytology compared to wet smear cytology for detection of Trichomonas vaginalis infection among adult women at a tertiary care center: A diagnostic evaluation study

  2023cites this paper
• The prevalence of Trichomonas vaginalis infection among the female population of Iran: a systematic review and meta-analysis.

  2023cites this paper
• Recurrent Infectious Vaginitis: A Practical Approach for the Primary Care Clinician.

  2023cites this paper
• Identification of volatile biomarkers of Trichomonas vaginalis infection in vaginal discharge and urine

  2023cites this paper
• Development of subunit selective substrates for Trichomonas vaginalis proteasome

  2023cites this paper
• Trichomonas tenax: A Neglected Protozoan Infection in the Oral Cavities of Humans and Dogs—A Scoping Review

  2023cites this paper
• Bovine trichomoniasis overview and testing

  2023cites this paper
• A STUDY ON PREVALENCE OF TRICHOMONIASIS AMONG FEMALE PATIENTS ATTENDING A TERTIARY CARE HOSPITAL OF BIHAR

  2023cites this paper
• Evaluation of direct microscopy and culture method for detection of Trichomonas vaginalis in vaginal discharge and urine samples

  2023cites this paper
• Correlational studies on clinical and laboratory diagnoses of Trichomonas vaginalis coinfection with HIV candidiasis and syphilis among women of reproductive age in Jalingo North-central Nigeria

  2023cites this paper
• A fluorescence-based assay for Trichomonas vaginalis drug screening

  2023cites this paper
• Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections

  2023cites this paper
• Trichomonas vaginalis adherence phenotypes and extracellular vesicles impact parasite survival in a novel in vivo model of pathogenesis

  2023cites this paper
• Trichomonas vaginalis and Associated Factors among Pregnant Women Attending Antenatal Care at Bule Hora University Teaching Hospital, Oromia Region, Southern Ethiopia

  2023cites this paper
• Investigation of Trichomonas gallinae in passerines

  2023cites this paper
• Genetic Variability of the Internal Transcribed Spacer and Pyruvate:Ferredoxin Oxidoreductase Partial Gene of Trichomonas vaginalis from Female Patients

  2023cites this paper
• La trichomonose urogénitale, une infection sexuellement transmissible parasitaire fréquente

  2023cites this paper
• Multiple Regulations of Parasitic Protozoan Viruses: A Double-Edged Sword for Protozoa

  2023cites this paper
• Association between the infections of Trichomonas vaginalis and uterine cervical human papillomavirus: a meta-analysis

  2023cites this paper
• Bovine Trichomoniasis

  2023cites this paper
• Trichomonosis in Austrian Songbirds—Geographic Distribution, Pathological Lesions and Genetic Characterization over Nine Years

  2022cites this paper
• Molecular characterization of Trichomonas infections in women of Ilam City, southwestern Iran

  2022cites this paper
• Local cytokine/chemokine profiles in BALB/c and C57BL/6 mice in response to T. vaginalis infection.

  2022cites this paper
• Effects of amiodarone, amioder, and dronedarone on Trichomonas vaginalis

  2022cites this paper
• Trichomoniasis, a new look at a common but neglected STI in African descendance population in the United States and the Black Diaspora. A review of its incidence, research prioritization, and the resulting health disparities.

  2022cites this paper
• Lab-on-a-chip for analysis of blood

  2022cites this paper
• Sexually Transmitted Diseases in Northern Israel: Insights From a Large Referral Laboratory

  2022cites this paper
• The prevalence and risk factors of Trichomonas vaginalis in Wuhan and the Tibetan area, China: a two-center study

  2022cites this paper
• Induction of apoptosis by essential oil of Dracocephalum kotschyi on Trichomonas vaginalis

  2022cites this paper
• Activity of Apo-Lactoferrin on Pathogenic Protozoa

  2022cites this paper
• Prevalence of Trichomonas vaginalis in Urine Samples of Women Attending Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Awka, Southeastern Nigeria

  2022cites this paper
• The state of the art of extracellular vesicle research in protozoan infection

  2022cites this paper
• Trichomonas vaginalis infection impairs anion secretion in vaginal epithelium

  2021cites this paper
• Atomic Structure of the Trichomonas vaginalis Double-Stranded RNA Virus 2

  2021cites this paper
• Gardnerella vaginalis and Trichomonas vaginalis infections as risk factors for persistence and progression of low-grade precancerous cervical lesions in HIV-1 positive women.

  2021cites this paper
• A review study on the anti-trichomonas activities of medicinal plants

  2021cites this paper
• Chitosan-based systems aimed at local application for vaginal infections.

  2021cites this paper
• A systematic review of Trichomonas vaginalis in Turkey from 2002 to 2020.

  2021cites this paper
• Molecular Epidemiologic Study of Male Trichomoniasis in Hamadan, Western Iran

  2021cites this paper
• Ease of use and validity testing of a point-of-care fast test for parasitic vaginosis self-diagnosis.

  2021cites this paper
• Paradigms of Protist/Bacteria Symbioses Affecting Human Health: Acanthamoeba species and Trichomonas vaginalis

  2021cites this paper
• Prevalence of Trichomonas vaginalis in women attended at a private laboratory.

  2021cites this paper
• First identification of telomeric DNA sequences in Trichomonas vaginalis.

  2021cites this paper
• AN OVERVIEW ON TRICHOMONAS VAGINALIS WITH REFERENCE TO EGYPT

  2021cites this paper
• Comparison of diagnostic methods and analysis of socio-demographic factors associated with Trichomonas vaginalis infection in Sri Lanka

  2021cites this paper
• Drug Resistance in Reproductive Diseases

  2021cites this paper
• Prevalence of Trichomonas vaginalis and its correlation with socio-demographic variables in pregnant women in Al-Diwaniya, Iraq

  2021cites this paper
• Long-term consequences of sexually transmitted infections on men’s sexual function: A systematic review

  2021cites this paper
• Concordance Between Clinical and Laboratory Diagnosis of Abnormal Vaginal Discharge in Chilean Women

  2021cites this paper
• Diagnostic Testing of Sexually Transmitted Infections AHS – G2157

  2021cites this paper
• A review on Trichomonas vaginalis infections in women from Africa

  2021cites this paper
• DFT Study and Antiparasitic Activity of Some Azo Dyes Containing Uracil

  2021cites this paper
• Multiple occurrences of pathologies suggesting a common and severe bone infection in a population of the Australian Pleistocene giant, Genyornis newtoni (Aves, Dromornithidae)

  2021cites this paper
• Immunological and Cytopathological Assessment of Trichomonas vaginalis Infection in Asymptomatic and Symptomatic Females at Menoufia Governorate, Egypt

  2020cites this paper
• Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis among women with genitourinary infection and pregnancy-related complications in Tehran: A cross-sectional study

  2020cites this paper
• Studies on Cytological Anomalies of Microbial Co-infections in Cervical Lesions

  2020cites this paper
• A hospital-based study on the prevalence of trichomoniasis and evaluation of accuracy of various diagnostic techniques

  2020cites this paper
• Correlates of trichomoniasis among female sex workers who inject drugs in two Mexico-US border cities

  2020cites this paper
• Study of Some Immunological Parameters with Level of Iron in Women Infected with Trichomonas Vaginalis

  2020cites this paper
• Trichomonas vaginalis: pathogenesis and its role in cervical cancer

  2020influential citation
• Update on the Diagnosis of Sexually Transmitted Infections

  2020cites this paper
• Update on the Diagnosis of Sexually Transmitted Infections.

  2020cites this paper
• Biochemical and structural characterisation of a protozoan beta-carbonic anhydrase from Trichomonas vaginalis

  2020cites this paper
• Gardnerella vaginalis and Trichomonas vaginalis infections and the risk of persistence or progression of low-grade cervical intraepithelial neoplasia.

  2020cites this paper
• Vaginitis and Cervicitis

  2020cites this paper
• The First Detection of Co-Infection of Double-Stranded RNA Virus 1, 2 and 3 in Iranian Isolates of Trichomonas vaginalis

  2020cites this paper
• PATTERN OF BACTERIA VAGINOSIS & RISK FACTORS AMONG PREGNANT WOMEN ATTENDING A SECONDARY HOSPITAL ATNIGER STATE, NIGERIA

  2020cites this paper